vs
ALERUS FINANCIAL CORP（ALRS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ALERUS FINANCIAL CORP的1.7倍（$75.5M vs $45.2M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 18.0%），ALERUS FINANCIAL CORP自由现金流更多（$58.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -2.5%）
阿勒鲁斯金融公司（品牌简称Alerus）是一家连锁金融机构，总部位于北达科他州大福克斯，网点分布在北达科他、明尼苏达、威斯康星与亚利桑那州，为客户提供银行、抵押贷款、财富管理以及退休规划等多种金融服务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ALRS vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$45.2M
营收增速更快
PBYI
高出9.7%
18.0%
自由现金流更多
ALRS
多$44.4M
$14.4M
两年增速更快
PBYI
近两年复合增速
-2.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.2M | $75.5M |
| 净利润 | $-33.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -96.0% | 22.7% |
| 净利率 | -73.2% | — |
| 营收同比 | 18.0% | 27.7% |
| 净利润同比 | -49232.8% | — |
| 每股收益（稀释后） | $-1.27 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALRSPBYI
| Q4 25 | $45.2M | $75.5M | ||
| Q3 25 | $72.6M | $54.5M | ||
| Q2 25 | $74.8M | $52.4M | ||
| Q1 25 | $68.8M | $46.0M | ||
| Q4 24 | $72.2M | $59.1M | ||
| Q3 24 | $50.9M | $80.5M | ||
| Q2 24 | $51.4M | $47.1M | ||
| Q1 24 | $47.5M | $43.8M |
净利润ALRSPBYI
| Q4 25 | $-33.1M | — | ||
| Q3 25 | $16.9M | $8.8M | ||
| Q2 25 | $20.3M | $5.9M | ||
| Q1 25 | $13.3M | $3.0M | ||
| Q4 24 | $-67.0K | — | ||
| Q3 24 | $5.2M | $20.3M | ||
| Q2 24 | $6.2M | $-4.5M | ||
| Q1 24 | $6.4M | $-4.8M |
毛利率ALRSPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率ALRSPBYI
| Q4 25 | -96.0% | 22.7% | ||
| Q3 25 | 30.4% | 17.6% | ||
| Q2 25 | 35.2% | 12.7% | ||
| Q1 25 | 25.5% | 8.7% | ||
| Q4 24 | -0.8% | 22.6% | ||
| Q3 24 | 13.4% | 27.4% | ||
| Q2 24 | 15.8% | -4.6% | ||
| Q1 24 | 17.9% | -5.3% |
净利率ALRSPBYI
| Q4 25 | -73.2% | — | ||
| Q3 25 | 23.3% | 16.2% | ||
| Q2 25 | 27.1% | 11.2% | ||
| Q1 25 | 19.4% | 6.5% | ||
| Q4 24 | -0.2% | — | ||
| Q3 24 | 10.2% | 25.2% | ||
| Q2 24 | 12.1% | -9.6% | ||
| Q1 24 | 13.5% | -11.0% |
每股收益（稀释后）ALRSPBYI
| Q4 25 | $-1.27 | $0.26 | ||
| Q3 25 | $0.65 | $0.17 | ||
| Q2 25 | $0.78 | $0.12 | ||
| Q1 25 | $0.52 | $0.06 | ||
| Q4 24 | $-0.06 | $0.40 | ||
| Q3 24 | $0.26 | $0.41 | ||
| Q2 24 | $0.31 | $-0.09 | ||
| Q1 24 | $0.32 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $67.2M | $97.5M |
| 总债务越低越好 | $59.2M | $22.7M |
| 股东权益账面价值 | $564.9M | $130.3M |
| 总资产 | $5.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.10× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ALRSPBYI
| Q4 25 | $67.2M | $97.5M | ||
| Q3 25 | $92.0M | $94.4M | ||
| Q2 25 | $80.9M | $96.0M | ||
| Q1 25 | $83.0M | $93.2M | ||
| Q4 24 | $61.2M | $101.0M | ||
| Q3 24 | $66.0M | $96.7M | ||
| Q2 24 | $438.1M | $96.8M | ||
| Q1 24 | $545.8M | $107.2M |
总债务ALRSPBYI
| Q4 25 | $59.2M | $22.7M | ||
| Q3 25 | $59.2M | $34.0M | ||
| Q2 25 | $59.1M | $45.3M | ||
| Q1 25 | $59.1M | $56.7M | ||
| Q4 24 | $59.1M | $68.0M | ||
| Q3 24 | $59.0M | $79.3M | ||
| Q2 24 | $59.0M | $90.7M | ||
| Q1 24 | $59.0M | $102.0M |
股东权益ALRSPBYI
| Q4 25 | $564.9M | $130.3M | ||
| Q3 25 | $550.7M | $115.3M | ||
| Q2 25 | $533.2M | $104.7M | ||
| Q1 25 | $514.2M | $97.1M | ||
| Q4 24 | $495.4M | $92.1M | ||
| Q3 24 | $386.5M | $71.1M | ||
| Q2 24 | $373.2M | $48.5M | ||
| Q1 24 | $371.6M | $51.0M |
总资产ALRSPBYI
| Q4 25 | $5.2B | $216.3M | ||
| Q3 25 | $5.3B | $202.9M | ||
| Q2 25 | $5.3B | $194.9M | ||
| Q1 25 | $5.3B | $196.2M | ||
| Q4 24 | $5.3B | $213.3M | ||
| Q3 24 | $4.4B | $220.7M | ||
| Q2 24 | $4.4B | $205.0M | ||
| Q1 24 | $4.3B | $214.1M |
负债/权益比ALRSPBYI
| Q4 25 | 0.10× | 0.17× | ||
| Q3 25 | 0.11× | 0.30× | ||
| Q2 25 | 0.11× | 0.43× | ||
| Q1 25 | 0.11× | 0.58× | ||
| Q4 24 | 0.12× | 0.74× | ||
| Q3 24 | 0.15× | 1.12× | ||
| Q2 24 | 0.16× | 1.87× | ||
| Q1 24 | 0.16× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $58.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 130.2% | 19.1% |
| 资本支出强度资本支出/营收 | 19.3% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $102.4M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ALRSPBYI
| Q4 25 | $67.5M | $14.4M | ||
| Q3 25 | $32.8M | $9.7M | ||
| Q2 25 | $10.7M | $14.1M | ||
| Q1 25 | $7.7M | $3.6M | ||
| Q4 24 | $21.7M | $15.6M | ||
| Q3 24 | $20.2M | $11.0M | ||
| Q2 24 | $-12.5M | $1.0M | ||
| Q1 24 | $11.7M | $11.2M |
自由现金流ALRSPBYI
| Q4 25 | $58.8M | $14.4M | ||
| Q3 25 | $30.3M | $9.7M | ||
| Q2 25 | $7.6M | $14.1M | ||
| Q1 25 | $5.7M | $3.6M | ||
| Q4 24 | $9.4M | $15.6M | ||
| Q3 24 | $17.4M | $11.0M | ||
| Q2 24 | $-16.1M | $1.0M | ||
| Q1 24 | $10.8M | — |
自由现金流率ALRSPBYI
| Q4 25 | 130.2% | 19.1% | ||
| Q3 25 | 41.8% | 17.7% | ||
| Q2 25 | 10.1% | 26.8% | ||
| Q1 25 | 8.2% | 7.7% | ||
| Q4 24 | 13.0% | 26.4% | ||
| Q3 24 | 34.2% | 13.7% | ||
| Q2 24 | -31.4% | 2.1% | ||
| Q1 24 | 22.8% | — |
资本支出强度ALRSPBYI
| Q4 25 | 19.3% | 0.0% | ||
| Q3 25 | 3.4% | 0.0% | ||
| Q2 25 | 4.2% | 0.0% | ||
| Q1 25 | 3.0% | 0.1% | ||
| Q4 24 | 17.1% | 0.0% | ||
| Q3 24 | 5.4% | 0.0% | ||
| Q2 24 | 7.2% | 0.0% | ||
| Q1 24 | 1.9% | 0.0% |
现金转化率ALRSPBYI
| Q4 25 | — | — | ||
| Q3 25 | 1.94× | 1.10× | ||
| Q2 25 | 0.53× | 2.41× | ||
| Q1 25 | 0.58× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.88× | 0.54× | ||
| Q2 24 | -2.01× | — | ||
| Q1 24 | 1.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALRS
| Other | $17.3M | 38% |
| Retirement And Benefit Services | $17.3M | 38% |
| Wealth Management | $7.4M | 16% |
| Mortgage Banking | $3.2M | 7% |
PBYI
暂无分部数据
